References
- Schmitt H., Schmitt H., Boissier J. R., Giuidicelli J. F. Centrally mediated decrease in sympathetic tone induced by 2- (2,6-dichlorophenylamino)-2-imidazoline (St. 155, Catapressan). Eur J Pharmacol. 1967; 2: 147–148
- Reid J. L., Wing L. M.H., Mathias C. J., Frankel H. L., Neill E. The central hypotensive effect of clonidine: studies in tetraplegic subjects. Clinical Pharmacology and Therapeutics 1977; 21: 375–381
- Mathias C. J., Reid J. L., Wing L. M.H., Frankel H. L., Christensen N. J. Antihypertensive effects of clonidine in tetraplegic subjects devoid of central sympathetic control. Clin Sci Mol Med. 1979; 57: 425–428s
- Nayler W. G., Price J. M., Swann J. D., McInnes I., Race D., Lowe T. E. Effect of the hypotensive drug ST 155 (Catapress) on the heart and the peripheral circulation. J Pharmacol Exp Ther 1968; 164: 45–59
- Constantine J. W., McShane W. K. Analysis of cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (catapressan). Eur J Pharmacol. 1968; 4: 109–123
- Grant R. T., Bland E. F. Observations on arteriovenous anastomosis in human skin and in the birds foot with special reference to the reaction to cold. Heart. 1931; 15: 385–407
- Pickering G W. The vasomotor regulation of heat loss from human skin in relation to external temperature. Heart. 1933; 16: 115–135
- Boissier J. R., Guidicelli J. F., Fichelle J., Schmitt H., Schmitt H. Cardiovascular effects of 2-(2,6, dichlorophenylamino)-2-imidazoline hydrochloride (St. 155).1. Peripheral sympathetic system. Eur. J. Pharmacol. 1968; 2: 333–339
- Mathias C. J., Christensen N. J., Corbett J. L., Frankel H. L., Goodwin T. S., Peart W. S. Plasma catecholamines, plasma renin activity and plasma aldosterone in tetraplegic man. horizontal and tilted. 1975; 49: 291–299